Literature DB >> 9185222

Pathology of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency caused by the G1528C mutation.

T Tyni1, J Rapola, A Paetau, A Palotie, H Pihko.   

Abstract

Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency is a recently discovered disorder affecting the mitochondrial beta-oxidation of fatty acids. There have been few reports of the pathologic findings in beta-oxidation defects. We examined pathologic specimens from 16 patients with this disorder (11 patients were homozygous for the common mutation G1528C, 5 patients were siblings with a similar clinical presentation). Autopsies were performed on all 15 patients who died, and liver biopsy specimens were available from 8 patients. Hepatomegaly and steatosis of the liver, found in every patient, were often combined with fibrosis or cirrhosis. Cardiomegaly and accumulation of fat in the myocardium, renal tubules, and skeletal muscle were found in many patients. A detailed neuropathologic examination was performed on six patients, and brain specimens obtained at autopsy were examined in four others. In general, neuropathologic findings were mild and unspecific, but vacuolization was detected in the deep gray matter and in the cerebellum and brain stem nuclei of five patients. In one patient the vacuolization was prominent; in the other four it was milder and more focal. The vacuoles seemed to be either in the neuropil or associated with swollen hydropic cells. The uniform pattern of histopathologic changes facilitates the diagnostics in this severe disorder, allowing opportunities for therapy and prenatal diagnosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9185222

Source DB:  PubMed          Journal:  Pediatr Pathol Lab Med        ISSN: 1077-1042


  12 in total

Review 1.  Acute fatty liver of pregnancy.

Authors:  H Ko; Eric M Yoshida
Journal:  Can J Gastroenterol       Date:  2006-01       Impact factor: 3.522

2.  A genome scan for renal function among hypertensives: the HyperGEN study.

Authors:  A T DeWan; D K Arnett; L D Atwood; M A Province; C E Lewis; S C Hunt; J Eckfeldt
Journal:  Am J Hum Genet       Date:  2000-12-12       Impact factor: 11.025

3.  Urgent metabolic service improves survival in long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency detected by symptomatic identification and pilot newborn screening.

Authors:  Jolanta Sykut-Cegielska; Wanda Gradowska; Dorota Piekutowska-Abramczuk; Brage S Andresen; Rikke K J Olsen; Mariusz Ołtarzewski; Maciej Pronicki; Magdalena Pajdowska; Anna Bogdańska; Ewa Jabłońska; Barbara Radomyska; Katarzyna Kuśmierska; Małgorzata Krajewska-Walasek; Niels Gregersen; Ewa Pronicka
Journal:  J Inherit Metab Dis       Date:  2010-11-20       Impact factor: 4.982

4.  A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency.

Authors:  M He; S L Rutledge; D R Kelly; C A Palmer; G Murdoch; N Majumder; R D Nicholls; Z Pei; P A Watkins; J Vockley
Journal:  Am J Hum Genet       Date:  2007-06-04       Impact factor: 11.025

5.  Glucose-free medium exacerbates microvesicular steatosis in cultured skin fibroblasts of genetic defects of fatty acid oxidation. A novel screening test.

Authors:  D L Renaud; V Edwards; G J Wilson; I Tein
Journal:  J Inherit Metab Dis       Date:  2002-11       Impact factor: 4.982

Review 6.  Impact of newborn screening on the reported incidence and clinical outcomes associated with medium- and long-chain fatty acid oxidation disorders.

Authors:  Deborah Marsden; Camille L Bedrosian; Jerry Vockley
Journal:  Genet Med       Date:  2021-01-25       Impact factor: 8.822

7.  scully, an essential gene of Drosophila, is homologous to mammalian mitochondrial type II L-3-hydroxyacyl-CoA dehydrogenase/amyloid-beta peptide-binding protein.

Authors:  L Torroja; D Ortuño-Sahagún; A Ferrús; B Hämmerle; J A Barbas
Journal:  J Cell Biol       Date:  1998-05-18       Impact factor: 10.539

8.  Fatal pitfalls in newborn screening for mitochondrial trifunctional protein (MTP)/long-chain 3-Hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency.

Authors:  Amelie S Lotz-Havla; Wulf Röschinger; Katharina Schiergens; Katharina Singer; Daniela Karall; Vassiliki Konstantopoulou; Saskia B Wortmann; Esther M Maier
Journal:  Orphanet J Rare Dis       Date:  2018-07-20       Impact factor: 4.123

Review 9.  Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle.

Authors:  Suzan J G Knottnerus; Jeannette C Bleeker; Rob C I Wüst; Sacha Ferdinandusse; Lodewijk IJlst; Frits A Wijburg; Ronald J A Wanders; Gepke Visser; Riekelt H Houtkooper
Journal:  Rev Endocr Metab Disord       Date:  2018-03       Impact factor: 6.514

Review 10.  Mitochondrial dysfunction in fatty acid oxidation disorders: insights from human and animal studies.

Authors:  Moacir Wajner; Alexandre Umpierrez Amaral
Journal:  Biosci Rep       Date:  2015-11-20       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.